DNMT1 and synovial sarcoma: The increased expression of non-fusion–targeted genes that were relatively suppressed transcriptionally at baseline in synovial sarcoma cells had a more prominent impact on the application of DNMT1 silencing, which included genes that drove mesenchymal differentiation and extracellular matrix production, as well as tumor suppressor genes.